Health Experts Warn of Nicotine Pouches’ Risks
Health experts in Australia have raised serious concerns about the growing availability of nicotine pouches, urging the government to take immediate action to prevent a potential public health crisis. The Australian Medical Association (AMA) has submitted a detailed report to the Therapeutics Goods Administration, highlighting the need for stricter regulations to address the current gaps in oversight.
The federal AMA vice president, associate professor Julian Rait, emphasized that the government must act swiftly before these products become deeply embedded in the market. He warned that the lack of regulation is allowing unapproved nicotine products to enter the country, posing significant risks to public health.
“These pouches are being marketed with youth-attractive branding and sold online with minimal friction, despite having no approved therapeutic indication in Australia,” he said. This alarming trend is particularly concerning given the increasing accessibility of these products through online platforms.
Currently, there are no approved nicotine pouches listed on the Australian Register of Therapeutic Goods (ARTG). This means that many of the products available in the market are not subject to the same rigorous safety and efficacy standards as other medicinal products.
Mr Rait pointed to a non-industry study that found some nicotine pouches contain up to 150mg of nicotine. He explained that even a 30mg pouch is comparable to the nicotine content of one cigarette. This high level of nicotine can lead to various negative health effects, including mouth and gum irritation, upset stomachs, nausea, and high blood pressure.
The AMA has also highlighted the rapid growth of online promotion and sales of these products, along with the increasing use of synthetic nicotine. This has exposed significant gaps in current regulations and enforcement mechanisms. Without stronger, technology-neutral rules and consistent national enforcement, suppliers may continue to exploit these loopholes.
“We need stronger safeguards, including effective online compliance and take-down processes, clear and consistent health warnings, child-resistant packaging, and better monitoring of adverse events and poisoning presentations to inform ongoing regulatory action,” A/Prof Rait said.
The AMA submission proposes changes that would create uniform national rules for nicotine pouches. These measures aim to simplify the regulatory landscape for state and territory governments, which are currently handling this new product using various inconsistent approaches.
“While some jurisdictions have acted — such as South Australia and Queensland under their tobacco legislation — others have not,” Mr Rait said. “Action at the federal government level will help harmonise expectations, improve inter-jurisdictional consistency, and strengthen the overall enforcement environment.”
The call for action comes amid growing concerns about the long-term health impacts of nicotine pouches, particularly among young people. With the potential for addiction and other health complications, it is crucial that the government takes decisive steps to protect public health and ensure that these products are properly regulated.
